Conceptrichtlijn colorectaal carcinoom 2013 - Oncoline

9508950995109511951295139514951595169517951895199520952195229523Bijlage 18Kenmerken standaard pathologieverslagKenmerken/items Naam eerste auteur en jaartal Niveau vanbewijs†ColoncarcinoomTumortype*TumorgrootteTumorgraderingdifferentiatie)*Betrokkenheid* plusaantal (positieve)lymfklierenExtramurale vasculaire invasie*pT en pN (TNMstadium)*Afstand van tumor tot distale (ofdichtstbijzijnde) resectierandAchtergrondafwijkingBranston 2002 30 , Bull 1997 33 , Jouret-Mourin 2004 111 , Keating IIB2003 118 , Monges 1998 161 , Rigby 1999 188 , Wei 2004 235Branston 2002 30 , Bull 1997 33 , Jouret-Mourin 2004 112 , Keating IV2003 118 , Monges 1998 161 , Rigby 1999 188 , Wei 2004 235(histologische Beattie 2003 15 , Branston 2002 30 , Bull 1997 33 , Jouret-Mourin IIA2004 112 , Keating 2003 118 , Monges 1998 161 , Rigby 1999 188 ,Wei 2004 235Beattie 2003 15 , Branston 2002 30 , Bull 1997 33 , Jouret-Mourin I2004 112 , Keating 2003 118 , Monges 1998 161 , Wei 2004 235Beattie 2003 15 , Branston 2002 30 , Bull 1997 33 , Jouret-Mourin I2004 112 , Keating 2003 118 , Monges 1998 161 , Wei 2004 235Beattie 2003 15 , Branston 2002 30 , Bull 1997 33 , Jouret-Mourin I2004 112 , Keating 2003 118 , Monges 1998 161 , Rigby 1999 188 ,Wei 2004 235Beattie 2003 15 , Bull 1997 33 , Jouret-Mourin 2004 112 , Keating2003 118 , Rigby 1999 188 , Wei 2004 235pathologische Beattie 2003 15 , Wei 2004 235Betrokkenheid apicale lymfklier Beattie 2003 15 , Rigby 1999 188Volledigheid resectie(tumor inresectieranden)*Lengte preparaatMacroscopische(‘appearance')Beattie 2003 15 , Bull 1997 33 , Jouret-Mourin 2004 112 , Monges I -IIA‡1998 161 , Wei 2004 235Bull 1997 33 , Jouret-Mourin 2004 112 , Monges 1998 161 , Rigby1999 188 , Wei 2004 235beschrijving Bull 1997 33 , Jouret-Mourin 2004 112 , Keating 2003 118 , Rigby1999 188 , Wei 2004 235Vasculaire ofJouret-Mourin 2004 112 , Keating 2003 118 , Monges 1998 161 , Ilymfatische invasieRigby 1999 188 , Wei 2004 (optioneel) 235Perineurale invasie Keating 2003 118 , Monges 1998 161 , Wei 2004 (optioneel) 235Beschrijving preparaat ontvangst Wei 2004 235enidentificatie)Aspect van de rand Wei 2004 (optioneel) 235Ontstekingsinfiltraat Wei 2004 (optioneel) 235* minimale dataset van the Royal College of Pathologists (UK);† niveau van bewijs opgesteld door College of American Pathologists 46 waarbij: Category I includes factors definitively proven to be of prognostic importance based on evidence frommultiple statistically robust published trials and generally used in patient management; Category IIA includes factors extensively studied biologically and/or clinically and repeatedly shownedto have prognostic value for outcome and/or predictive value for therapy that is of sufficient importanceto be included in the pathology report but that remains to be validated in statistically robust studies.Category IIB includes factors shown to be promising in multiple studies but lacking sufficient data forinclusion in category I or IIA; Category III includes factors not yet sufficiently studied to determine their prognostic value; Category IV includes factors well studied and shown to have no prognostic significance.Richtlijn Colorectaal carcinoom en Colorectale levermetastasen 2013 - CONCEPT 226